Close Menu

NEW YORK (360Dx) – Gradientech announced today it has completed a $4.6 million rights issue. The Uppsala, Sweden-based firm will use the funds for further development and early market introduction of its QuickMIC diagnostic system for ultra-rapid antibiotic susceptibility testing in cases of suspected sepsis.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.